Jeffrey Harris

Corporate Officer/Principal presso University of California San Diego

Consumer Services

Health Technology

Posizioni attive di Jeffrey Harris

Società	Posizione	Inizio	Fine
University of California San Diego	Corporate Officer/Principal	07/09/2009	-
Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum	Corporate Officer/Principal	07/09/2009	-

Società	Posizione	Inizio	Fine
American Otological Society, Inc.	Presidente	-	-
The Association for Research in Otolaryngology	Presidente	-	-
OTONOMY	Direttore/Membro del Consiglio	07/09/2009	-
OTONOMY	Fondatore	01/04/2008	-

University of Pennsylvania

Doctorate Degree

Distribuzione geografica

Stati Uniti	6
Francia	2

Posizioni

Corporate Officer/Principal	2
President	2
Director/Board Member	1

Settori

Consumer Services	3
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	4
Otonomy, Inc. Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA.	Health Technology
American Otological Society, Inc.
The Association for Research in Otolaryngology
Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum